Topics
Glioblastoma | Treatment | Immunotherapy | Landscape
Home > Publications > Topics > Glioblastoma > Treatment > Immunotherapy > Landscape
Guterres A, Filho PNS, Moura-Neto
V.
Breaking
Barriers: A Future Perspective on Glioblastoma Therapy with
mRNA-Based Immunotherapies and Oncolytic Viruses.
Vaccines
(Basel). 2024 Jan 8;12(1):61. doi:
10.3390/vaccines12010061. PMID:
38250874. Perspective. ˍ
Salvato I, Marchini A.
Immunotherapeutic
Strategies for the Treatment of Glioblastoma: Current Challenges
and Future Perspectives.
Cancers
(Basel). 2024 Mar 25;16(7):1276. doi:
10.3390/cancers16071276. PMID:
38610954. Review. ˍ
Schirrmacher V, Van Gool S, Stuecker W.
Individualized
Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical
Experience from a Single Institution.
Biomedicines.
2024 Mar 28;12(4):754. doi:
10.3390/biomedicines12040754. PMID:
38672110. Review. ˍ
McArdle SEB, Nagarajan D, Barish ME.
Editorial:
Improving responses to immunotherapy in glioblastoma
multiforme.
Front
Immunol. 2024 Apr 23;15:1407930. doi:
10.3389/fimmu.2024.1407930. PMID:
38715607. Editorial. ˍ
Xiong S, Qin B, Liu C, Pan Y.
Editorial:
Immunosuppression mechanisms and immunotherapy strategies in
glioblastoma.
Front
Cell Neurosci. 2024 Apr 25;18:1411330. doi:
10.3389/fncel.2024.1411330. PMID:
38725447. Editorial. ˍ
Xu H, Zhao X, Luo J.
Combination
of tumor antigen drainage and immune activation to promote a
cancer-immunity cycle against glioblastoma.
Cell
Mol Life Sci.
2024 Jun 22;81(1):275. doi:
10.1007/s00018-024-05300-5. PMID:
38907858. Review.
ˍ
*Lv K, Du X, Chen C, Yu Y.
Research
hotspots and trend of glioblastoma immunotherapy: a bibliometric
and visual analysis.
Front
Oncol. 2024 Aug 7;14:1361530. doi:
10.3389/fonc.2024.1361530. PMID:
39175478 Bibliometric analysis. ˍ
Ghosh MK, Kumar S, Begam S, Ghosh S, Basu M.
GBM
immunotherapy: Exploring molecular and clinical frontiers.
Life
Sci. 2024 Aug 28;356:123018. doi:
10.1016/j.lfs.2024.123018. PMID:
39214286. Review˰ ˍ
*Sloan L, Sen R, Liu C, Doucet M, Blosser L, Katulis L, Kamson DO,
Grossman S, Holdhoff M, Redmond KJ, Quon H, Lim M, Eberhart C,
Pardoll DM, Hu C, Ganguly S, Kleinberg LR.
Radiation
immunodynamics in patients with glioblastoma receiving
chemoradiation.
Front
Immunol. 2024 Sep 13;15:1438044. doi:
10.3389/fimmu.2024.1438044. PMID:
39346903. Observational study. ˍ
Ijaz M, Ullah Z, Aslam B, Khurshid M, Chen P, Guo B.
From
promise to progress: the dynamic landscape of glioblastoma
immunotherapy.
Drug
Discov Today. 2024 Sep 20;29(11):104188. doi:
10.1016/j.drudis.2024.104188. PMID:
39307298. Review˰ ˍ
Bhardwaj JS, Paliwal S, Singhvi G, Taliyan R.
Immunological
challenges and opportunities in glioblastoma multiforme: A
comprehensive view from immune system lens.
Life
Sci. 2024 Oct 1;357:123089. doi:
10.1016/j.lfs.2024.123089. PMID:
39362586. Review˰ ˍ
Liu Y, Zhou F, Ali H, Lathia JD, Chen P.
Immunotherapy
for glioblastoma: current state, challenges, and future
perspectives.
Cell
Mol Immunol. 2024 Oct 15. doi:
10.1038/s41423-024-01226-x. PMID:
39406966.
Review.
ˍ
Norollahi SE, Yousefi B, Nejatifar F, Yousefzadeh-Chabok S,
Rashidy-Pour A, Samadani AA.
Practical
immunomodulatory landscape of glioblastoma multiforme (GBM)
therapy.
J
Egypt Natl Canc Inst. 2024 Oct 28;36(1):33. doi:
10.1186/s43046-024-00240-4. PMID:
39465481. Review. ˍ
Ng AT, Steve T, Jamouss KT, Arham A, Kawtharani S, Assi HI.
The
challenges and clinical landscape of glioblastoma immunotherapy.
CNS
Oncol. 2024 Oct 29;13(1):2415878. doi:
10.1080/20450907.2024.2415878. PMID:
39469854. Review. ˍ
He C, Xiong P, Zeng C, Qiu X, Long T, Song H.
Bibliometric
analysis of the top
100 most cited articles on the immunotherapy for glioblastoma.
Childs
Nerv Syst.
2024 Dec 5;41(1):33. doi:
10.1007/s00381-024-06693-1. PMID:
39633087. Bibliometric analysis˰
ˍ